grupo gedeon
DESCRIPTION
Group presentation GedeonHomos Laboratories Medical - Laboratories Vihcorp - Pharmaceutical Care Center ips - green lightingTRANSCRIPT
![Page 1: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/1.jpg)
CORPORATE OVERVIEW
• COLOMBIA• A LEADER COMPANY HAS BORN
![Page 2: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/2.jpg)
WHO WE ARE We are a dynamic and efficient company which expertise is based on a
knowledgeable and resourceful team that works locally as well asinternationally.
Our company´s mission is to bring to our market, new advances andtechnologies which represent evolution and new hopes for the community ofpatients and for the pharmaceutical market .
![Page 3: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/3.jpg)
OUR GROUP OF ENTERPRISES
HOMOS MEDICAL LABORATORY : Strategicpartner in defence of the label. Representation anddistribution of oncology, HIV and hematologicproducts.
VHICORP LABORATORIES: Brokerpharmacist. Strategic partner in support of yourdevelopment and growth. Representation anddistribution of critical care medicines andspecialised products for hospitals.
CAFI IPS: Pharmaceutical Basic Healthcare Centre where HIV patients receive primary aid.
BIOCORP: Natural alternative to your health. Free medicine prescription (OTC)
![Page 4: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/4.jpg)
COMPANY PROFILE
GIDEON GROUP was founded as a result of the demandof our own set of costumers.
It was created because of the need to consolidate a groupof companies which goal is to provide special attention toour costumers and to the entire pharmaceutical marketwith high standards and quality products and services.
GIDEON GROUP is a group of companies which has beenin the market for over eight years.
Today we have transformed our model of business withinthe group reflecting on the demand and the best target ofpotential costumers.
The integration of these businesses pretends to aid andassist the different needs of our clients such ashemophilia, HIV, oncology, orphan drugs, metabolicdiseases, among others.
![Page 5: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/5.jpg)
OUR HOLDING
Regulatory affairs support
Pharmacovigilance Marketing
management Marketing research Promotional
activities Medical Direction Call reps force in
main cities
Sales to institutions and drugstores
Supply drugs and medical devices to HMO´s patients
Supply and distribute products to patient in ICU
Supply products to private patients
Home delivery program
Attention and Integral treatment
Patient Home Care Management Disease
supported by the program
CRM program to follow up patients in: Dosage Frequency Refills
Importer Market Research Market
development Owner of
Licensing and Brands Projects
![Page 6: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/6.jpg)
CORPORATE VALUES
CONTINUE GROWING
QUALITY
INNOVATION
CREATIVITY
COMMUNITY SERVICE
EFFICIENCY
CONFIDENCE/
TRUST
![Page 7: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/7.jpg)
HOLDING TURN OVER
(*)Established 2006
Capital 100 % Colombian
Turn Over $ Usd 1.000.000
Market Share 1,2 Values 2,3 % Units (I.M.S. ) Distribution
Channels
Sales Mix 80 % Market & distribution Local products
20 % Own Operation
Employees 11 Administrative , 23 Sales and Line Force
![Page 8: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/8.jpg)
HOLDING SALES EVOLUTION
0
500000
1000000
1500000
2000000
2500000
3000000
2006 2007 2008 2009
HOMOS MEDICAL
VIHCORP
CAFI IPS
US DOLLARS
![Page 9: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/9.jpg)
OUR LINES OF THERAPIES
PARENTERAL NUTRITION, NUTRITION ENTERAL AND BIOLOGICAL LINE
CRITICAL CARE
ONCO- VIH LINE PRODUCTS
TRANSPLANTS AND HORMONAL LINE
![Page 10: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/10.jpg)
MARKET DISTRIBUTION CAPABILITY
Distribution Channel
Main sales approach
Accounts Number
Market coverage Number of annual invoices served
Direct Sales IPS
Specialist Pharmacy
162 100% Oncology - arv-blood.74% distributors hospital
4,282
Distributors Purchase manager
195 •95% of dealers 2,873
Hospitals Tender 18 •100% of high complexity hospitals
•10% of level 1-2
446
Direct Sales EPS
Tender Recruitment
4 35% of patients with catastrophic diseases
129
![Page 11: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/11.jpg)
MARKETING & DIRECTION STAFF
BOARD OF DIRECTORS
B.DEVELOPMENT DIRECTOR
MEDICAL HOLDING DIRECTOR
SALES NATIONAL MANAGER
ADMINISTRATIVE MANAGER
KEY ACCOUNT ONCO- ARV LINE
KEY ACCOUNT HOSPITAL
KEY ACCOUNT CRITICAL CARE
TENDER´S REP. K.A.
REPS. TEAM HOMOS MEDICAL•Bogota(2)•Cali(1)•Medellin(1)•Costa (2)
REPS. TEA VHICORP LAB.
•Bogota(2)•Cali(2)•Medellin(2)•Costa (4)
REPS. TEA VHICORP LAB.
•Bogota(2)•Cali(1)•Medellin(2)•Costa (2)
MARKETING COORDINATOR
![Page 12: GRUPO GEDEON](https://reader034.vdocuments.us/reader034/viewer/2022052602/5599e9ae1a28ab04508b45ee/html5/thumbnails/12.jpg)
STRATEGIC PARTNER IN DEFENCE OF THE LABEL.